177 related articles for article (PubMed ID: 8815886)
1. Glutathione is involved in the granular storage of dopamine in rat PC 12 pheochromocytoma cells: implications for the pathogenesis of Parkinson's disease.
Drukarch B; Jongenelen CA; Schepens E; Langeveld CH; Stoof JC
J Neurosci; 1996 Oct; 16(19):6038-45. PubMed ID: 8815886
[TBL] [Abstract][Full Text] [Related]
2. Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. I. Release in the absence of vesicular transmitter stores.
Parker EM; Cubeddu LX
J Pharmacol Exp Ther; 1986 Apr; 237(1):179-92. PubMed ID: 3007736
[TBL] [Abstract][Full Text] [Related]
3. Pre-treatment with R-lipoic acid alleviates the effects of GSH depletion in PC12 cells: implications for Parkinson's disease therapy.
Bharat S; Cochran BC; Hsu M; Liu J; Ames BN; Andersen JK
Neurotoxicology; 2002 Oct; 23(4-5):479-86. PubMed ID: 12428720
[TBL] [Abstract][Full Text] [Related]
4. Effects of dopamine on the glutathione metabolism of cultured astroglial cells: implications for Parkinson's disease.
Hirrlinger J; Schulz JB; Dringen R
J Neurochem; 2002 Aug; 82(3):458-67. PubMed ID: 12153471
[TBL] [Abstract][Full Text] [Related]
5. (-)Schisandrin B ameliorates paraquat-induced oxidative stress by suppressing glutathione depletion and enhancing glutathione recovery in differentiated PC12 cells.
Lam PY; Ko KM
Biofactors; 2011; 37(1):51-7. PubMed ID: 21328628
[TBL] [Abstract][Full Text] [Related]
6. Trace amines inhibit the electrically evoked release of [3H]acetylcholine from slices of rat striatum in the presence of pargyline: similarities between beta-phenylethylamine and amphetamine.
Baud P; Arbilla S; Cantrill RC; Scatton B; Langer SZ
J Pharmacol Exp Ther; 1985 Oct; 235(1):220-9. PubMed ID: 3930699
[TBL] [Abstract][Full Text] [Related]
7. Glutathione deficiency potentiates manganese toxicity in rat striatum and brainstem and in PC12 cells.
Desole MS; Esposito G; Migheli R; Sircana S; Delogu MR; Fresu L; Miele M; de Natale G; Miele E
Pharmacol Res; 1997 Oct; 36(4):285-92. PubMed ID: 9425617
[TBL] [Abstract][Full Text] [Related]
8. Prevention of dopamine-induced cell death by thiol antioxidants: possible implications for treatment of Parkinson's disease.
Offen D; Ziv I; Sternin H; Melamed E; Hochman A
Exp Neurol; 1996 Sep; 141(1):32-9. PubMed ID: 8797665
[TBL] [Abstract][Full Text] [Related]
9. The effects of ascorbic acid on dopamine-induced death of PC12 cells are dependent on exposure kinetics.
Choi HY; Song JH; Park DK; Ross GM
Neurosci Lett; 2000 Dec; 296(2-3):81-4. PubMed ID: 11108986
[TBL] [Abstract][Full Text] [Related]
10. Differential sensitivity to hydrogen peroxide of dopaminergic and noradrenergic neurotransmission in rat brain slices.
Langeveld CH; Schepens E; Stoof JC; Bast A; Drukarch B
Free Radic Biol Med; 1995 Aug; 19(2):209-17. PubMed ID: 7649492
[TBL] [Abstract][Full Text] [Related]
11. Toxic and protective effects of L-dopa on mesencephalic cell cultures.
Mytilineou C; Han SK; Cohen G
J Neurochem; 1993 Oct; 61(4):1470-8. PubMed ID: 8376999
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the role of glutathione in repin-induced mitochondrial dysfunction, oxidative stress and dopaminergic neurotoxicity in rat pheochromocytoma (PC12) cells.
Tukov FF; Rimoldi JM; Matthews JC
Neurotoxicology; 2004 Dec; 25(6):989-99. PubMed ID: 15474617
[TBL] [Abstract][Full Text] [Related]
13. 3H-dopamine accumulation by rat brain synaptic vesicles in a membrane-impermeable medium.
Gershten MJ; Disbrow JK; Ruth JA
Life Sci; 1983 Jul; 33(4):323-9. PubMed ID: 6877025
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of reserpine and tetrabenazine on rat striatal synaptosomal dopamine biosynthesis and synaptosomal dopamine pools.
Kuczenski R
J Pharmacol Exp Ther; 1977 May; 201(2):357-67. PubMed ID: 870679
[TBL] [Abstract][Full Text] [Related]
15. Thioctic acid does not restore glutathione levels or protect against the potentiation of 6-hydroxydopamine toxicity induced by glutathione depletion in rat brain.
Seaton TA; Jenner P; Marsden CD
J Neural Transm (Vienna); 1996; 103(3):315-29. PubMed ID: 8739843
[TBL] [Abstract][Full Text] [Related]
16. Dopamine-melanin induces apoptosis in PC12 cells; possible implications for the etiology of Parkinson's disease.
Offen D; Ziv I; Barzilai A; Gorodin S; Glater E; Hochman A; Melamed E
Neurochem Int; 1997 Aug; 31(2):207-16. PubMed ID: 9220453
[TBL] [Abstract][Full Text] [Related]
17. In vivo mechanisms underlying dopamine release from rat nigrostriatal terminals: I. Studies using veratrine and ouabain.
Fairbrother IS; Arbuthnott GW; Kelly JS; Butcher SP
J Neurochem; 1990 Jun; 54(6):1834-43. PubMed ID: 2338544
[TBL] [Abstract][Full Text] [Related]
18. Glutathione depletion switches nitric oxide neurotrophic effects to cell death in midbrain cultures: implications for Parkinson's disease.
Canals S; Casarejos MJ; de Bernardo S; Rodríguez-Martín E; Mena MA
J Neurochem; 2001 Dec; 79(6):1183-95. PubMed ID: 11752059
[TBL] [Abstract][Full Text] [Related]
19. The ability of grafted human sympathetic neurons to synthesize and store dopamine: a potential mechanism for the clinical effect of sympathetic neuron autografts in patients with Parkinson's disease.
Nakao N; Shintani-Mizushima A; Kakishita K; Itakura T
Exp Neurol; 2004 Jul; 188(1):65-73. PubMed ID: 15191803
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial impairment as an early event in the process of apoptosis induced by glutathione depletion in neuronal cells: relevance to Parkinson's disease.
Merad-Boudia M; Nicole A; Santiard-Baron D; Saillé C; Ceballos-Picot I
Biochem Pharmacol; 1998 Sep; 56(5):645-55. PubMed ID: 9783733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
